Interestingly, we found that the expression level of LINC00460 was significantly positively correlated with the risk score of the stromal and immune cell-based prognostic model, suggesting that LINC00460 may serve as an immune regulator of CRC tumors. This evidence concerns the gene LINC00460 and colorectal carcinoma.